Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

CSE:RVV - Post by User

Revive Therapeutics Ltd. > Revive Therapeutics Provides Corporate Update on Psychedelic

<< Previous

Bullboard Posts

Next >>

Comment by TheIceMan3on Sep 21, 2020 9:13am

85 Views

Post# 31590270

RE:RE:Revive Therapeutics Provides Corporate Update on Psychedelic

Far from fluff news, it's an important part of the company, a space that is growing HUGE and will be a massive money maker at some point in time or be part of why they get bought out. MCUR is coming to market today and this is gonna be an awesome time for investors IMO.

We can only listen to COOLIO/ Lil Ricky's BS so often.